Core Viewpoint - Eli Lilly (LLY) is positioned to potentially continue its earnings-beat streak in the upcoming report, having a history of exceeding earnings estimates, particularly in the last two quarters with an average surprise of 14.54% [1] Earnings Performance - For the last reported quarter, Eli Lilly achieved earnings of $7.02 per share, surpassing the Zacks Consensus Estimate of $6.02 per share, resulting in a surprise of 16.61% [2] - In the previous quarter, the company was expected to report earnings of $5.61 per share but delivered $6.31 per share, yielding a surprise of 12.48% [2] Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Eli Lilly, with a positive Zacks Earnings ESP (Expected Surprise Prediction), indicating a strong likelihood of an earnings beat [5] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have historically produced a positive surprise nearly 70% of the time, suggesting a high probability of exceeding consensus estimates [6] Earnings ESP Metric - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [7] - Eli Lilly currently has an Earnings ESP of +0.05%, indicating recent bullish sentiment among analysts regarding the company's earnings prospects [8] Upcoming Earnings Report - The next earnings report for Eli Lilly is expected to be released on February 4, 2026, and the combination of a positive Earnings ESP and a Zacks Rank of 3 suggests a potential for another earnings beat [8]
Will Lilly (LLY) Beat Estimates Again in Its Next Earnings Report?